Stephen D. Lee

Stephen D. Lee

Auto-generated profile, based on publicly available information

Stephen D. Lee

Department of Pathology and Laboratory Medicine, University of California, Los Angeles, USA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2008 in Nature Reviews Drug Discovery
Verified
Journal Article
Closed access
KWKishor M. Wasan
Kishor M. Wasan
DBDion R. Brocks
Dion R. Brocks
SLStephen D. Lee
Stephen D. Lee
KSKristina Sachs-Barrable
Kristina Sachs-Barrable
STSheila J. Thornton
Sheila J. Thornton

23 October 2019 in eLife
Verified
Journal Article
Open access
Prashant RajbhandariPrashant Rajbhandari
Prashant Rajbhandari
DADouglas Arneson
Douglas Arneson
SHSydney K Hart
Sydney K Hart
IAIn Sook Ahn
In Sook Ahn
GDGraciel Diamante
Graciel Diamante
PTPeter Tontonoz
Peter Tontonoz
Immune cells are vital constituents of the adipose microenvironment that influence both local and systemic lipid metabolism. Mice lacking IL10 have enhanced thermogenesis, but the roles of specific cell types in the metabolic response to IL10 remain to be defined. We demonstrate here that selective loss of IL10 receptor α in adipocytes recapitulates the beneficial effects of global IL10 deletion, and that local crosstalk between IL10-producing immune cells and adipocytes is a determinant of thermogenesis and systemic energy balance. Single Nuclei Adipocyte RNA-sequencing (SNAP-seq) of subcutaneous adipose tissue defined a metabolically-active mature adipocyte subtype characterized by robust expression of genes involved in thermogenesis whose transcriptome was selectively responsive to IL10Rα deletion. Furthermore, single-cell transcriptomic analysis of adipose stromal populations identified lymphocytes as a key source of IL10 production in response to thermogenic stimuli. These findings implicate adaptive immune cell-adipocyte communication in the maintenance of adipose subtype identity and function.

1 September 2015 in Atherosclerosis
Verified
Journal Article
Closed access
SLStephen D. Lee
Stephen D. Lee
PTPeter Tontonoz
Peter Tontonoz

9 November 2015 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
ABAnais BRIOT
Anais BRIOT
MCMete Civelek
Mete Civelek
ASAtsuko Seki
Atsuko Seki
KHKaren Hoi
Karen Hoi
JMJulia J. Mack
Julia J. Mack
MIM. Luisa Iruela-Arispe
M. Luisa Iruela-Arispe
Although much progress has been made in identifying the mechanisms that trigger endothelial activation and inflammatory cell recruitment during atherosclerosis, less is known about the intrinsic pathways that counteract these events. Here we identified NOTCH1 as an antagonist of endothelial cell (EC) activation. NOTCH1 was constitutively expressed by adult arterial endothelium, but levels were significantly reduced by high-fat diet. Furthermore, treatment of human aortic ECs (HAECs) with inflammatory lipids (oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine [Ox-PAPC]) and proinflammatory cytokines (TNF and IL1β) decreased Notch1 expression and signaling in vitro through a mechanism that requires STAT3 activation. Reduction of NOTCH1 in HAECs by siRNA, in the absence of inflammatory lipids or cytokines, increased inflammatory molecules and binding of monocytes. Conversely, some of the effects mediated by Ox-PAPC were reversed by increased NOTCH1 signaling, suggesting a link between lipid-mediated inflammation and Notch1. Interestingly, reduction of NOTCH1 by Ox-PAPC in HAECs was associated with a genetic variant previously correlated to high-density lipoprotein in a human genome-wide association study. Finally, endothelial Notch1 heterozygous mice showed higher diet-induced atherosclerosis. Based on these findings, we propose that reduction of endothelial NOTCH1 is a predisposing factor in the onset of vascular inflammation and initiation of atherosclerosis.

1 March 2008 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
KSKristina Sachs-Barrable
Kristina Sachs-Barrable
SLStephen D. Lee
Stephen D. Lee
EWEllen K. Wasan
Ellen K. Wasan
STSheila J. Thornton
Sheila J. Thornton
KWKishor M. Wasan
Kishor M. Wasan

10 November 2023 in Science
Verified
Journal Article
Closed access
AFAlessandra Ferrari
Alessandra Ferrari
EWEmily Whang
Emily Whang
XXXu Xiao
Xu Xiao
JKJohn P. Kennelly
John P. Kennelly
BRBeatriz Romartinez-Alonso
Beatriz Romartinez-Alonso
PTPeter Tontonoz
Peter Tontonoz
Intestinal absorption is an important contributor to systemic cholesterol homeostasis. Niemann-Pick C1 Like 1 (NPC1L1) assists in the initial step of dietary cholesterol uptake, but how cholesterol moves downstream of NPC1L1 is unknown. We show that Aster-B and Aster-C are critical for nonvesicular cholesterol movement in enterocytes. Loss of NPC1L1 diminishes accessible plasma membrane (PM) cholesterol and abolishes Aster recruitment to the intestinal brush border. Enterocytes lacking Asters accumulate PM cholesterol and show endoplasmic reticulum cholesterol depletion. Aster-deficient mice have impaired cholesterol absorption and are protected against diet-induced hypercholesterolemia. Finally, the Aster pathway can be targeted with a small-molecule inhibitor to manipulate cholesterol uptake. These findings identify the Aster pathway as a physiologically important and pharmacologically tractable node in dietary lipid absorption.